News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
238 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21243)
Month
January (4451)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (221)
2 (198)
3 (246)
4 (134)
5 (2)
6 (26)
7 (189)
8 (263)
9 (229)
10 (265)
11 (138)
12 (2)
13 (5)
14 (238)
15 (260)
16 (218)
17 (239)
18 (111)
19 (1)
20 (3)
21 (103)
22 (312)
23 (250)
24 (321)
25 (115)
26 (6)
27 (5)
28 (328)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Business
Roivant Sciences Reports Financial Results for the Quarter Ended December 31, 2021 and Provides Business Update
Roivant today reported its financial results for the third fiscal quarter ended December 31, 2021 and provided an update on the Company’s operations.
February 14, 2022
·
17 min read
FDA
ASCENSIA DIABETES CARE ANNOUNCES FDA APPROVAL OF THE EVERSENSE E3 CONTINUOUS GLUCOSE MONITORING SYSTEM FOR USE FOR UP TO 6 MONTHS
Ascensia Diabetes Care has received approval from the U.S. Food and Drug Administration (FDA) for the next-generation Eversense ® E3 Continuous Glucose Monitoring (CGM) System.
February 14, 2022
·
2 min read
Schizophrenia Treatment Market: Rising incidence of this disorder to drive the market
The demand within the global schizophrenia treatment market has been increasing on account of the rising incidence of this disorder.
February 14, 2022
·
5 min read
Prefilled Safety Devices Market: Rising Awareness about Prefilled Safety Devices is Projected to Be a Key Driver of the Growth of the Market
Prefilled safety devices are devices developed as a result of the advancement of innovation in the conventional type of syringes, wherein the needles are created with safety system to anticipate any needle stick or some other needle-related wounds.
February 14, 2022
·
5 min read
Clinical Genomics Market: Continuous Innovation in Clinical Genomics to Be Major Driver
A genome is a complete set of DNA contained in a single cell of an organism. Genomics is a branch of genetics that studies the sequencing and interpretation of a living organism’s genome.
February 14, 2022
·
6 min read
Viral Vectors Manufacturing Market: The genetic disorders segment is anticipated to dominate the market
Gene therapy is one of the best treatment options for most chronic diseases. It involves inserting a functional copy of a gene into a defective cell.
February 14, 2022
·
5 min read
Biotech Bay
Mainz Biomed Expands ColoAlert Commercialization with German Laboratory MVZ Dr. Stein + Kollegen, Mönchengladbach
Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced a partnership with Labor MVZ Dr. Stein + Kollegen.
February 14, 2022
·
6 min read
DiviTum(R)TKa Results from PYTHIA Published in EJC
Biovica, active in cancer diagnostics, announces that the positive DiviTum®TKa results from the European multicenter study PYTHIA have been published in the highly ranked peer-reviewed scientific journal European Journal of Cancer.
February 14, 2022
·
4 min read
JN Nova Pharma and NRC Human Health Group Partnership to Move Pan-COVID19 Therapeutic into Clinical Development, their lead therapeutic product JN2019 neutralizes the SARS-CoV-2 variants of concern (VOCs), including Omicron
JN Nova Pharma is a private Canadian biotech company which has worked with an interdisciplinary team of researchers from the National Research Council of Canada’s Human Health Therapeutics Research Centre over the past year to develop a promising anti-COVID-19 biotherapeutic with enhanced protection for vulnerable patients.
February 14, 2022
·
2 min read
Biotech Bay
Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors
Fluidigm Corporation (Nasdaq:FLDM) today filed with the U.S. Securities and Exchange Commission to consider and vote upon various items related to the proposed and previously announced strategic capital infusion from leading life sciences investors Casdin Capital, LLC.
February 14, 2022
·
10 min read
Previous
7 of 24
Next